UBS forecasts AI-driven market growth in 2026, which AI sectors are most promising for investment?

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking about UBS's forecasts for AI-driven market growth in 2026 and which sectors are most promising for investment. First, I need to check the provided references to find any mentions of UBS discussing AI sectors. Looking through the references, Number 1 and 7 both mention UBS's report on private credit defaults, specifically noting that AI-related sectors are vulnerable. They mention that if there's a downturn in AI, up to 30% of newer firms with private credit could be impaired. Conversely, if AI drives widespread disruption, 40% of private credit assets might be affected. This suggests that AI is a key area UBS is watching, but it's a double-edged sword. Reference 3 talks about UBS partnering with HWAL Inc. and Momentum Media Fund to convert intellectual property into digital assets, focusing on Real-World Assets and tokenized bonds. This indicates UBS is involved in AI through digital asset partnerships, which ties into the broader AI-driven market growth. Reference 4 mentions UBS raising Medtronic's target price, highlighting strong performance in Cardiovascular and Neuroscience divisions, which are areas where AI can play a significant role. The Pulsed Field Ablation (PFA) technology mentioned is an AI-driven solution, showing UBS's confidence in AI applications in healthcare. Reference 5 discusses UBS collaborating with Ant International on blockchain-based cross-border payments, which is an AI-driven sector. This partnership suggests UBS is betting on AI in financial technology and cross-border solutions. Putting this together, the promising AI sectors according to UBS's activities and forecasts are healthcare (specifically medical devices and AI-driven treatments), financial technology (blockchain and cross-border payments), and digital assets (tokenization and IP conversion). However, the user should be cautious about the risks mentioned in the private credit defaults report, as AI sectors could face significant volatility. The user's profile shows interest in NASDAQ, which is tech-heavy, so aligning with AI sectors that have growth potential and are innovation-driven makes sense. The user's moderate risk tolerance and medium-long term horizon mean they should consider sectors with high growth potential but also be aware of the risks highlighted by UBS. ``` **Conclusion** 🚀 UBS identifies **healthcare technology**, **financial services innovation**, and **digital asset infrastructure** as the most promising AI-driven sectors for 2026, with **blockchain applications** and **AI-driven medical devices** leading the charge. However, investors must remain vigilant about sector-specific risks tied to private credit exposure and regulatory uncertainties . --- ### 📊 **Key AI Sectors Highlighted by UBS** | Sector | Key Opportunities | Risks & Considerations | |----------------------------|-----------------------------------------------------------------------------------|---------------------------------------------------------------------------------------| | **Healthcare Technology** | - AI-driven medical devices (e.g., Pulsed Field Ablation) | - Regulatory hurdles for AI integration in healthcare | | | - AI-powered diagnostics and personalized medicine | - High concentration of private credit exposure in AI firms | | **Financial Services** | - Blockchain-based cross-border payments (collaboration with Ant International) | - Market volatility in tokenized assets | | | - Tokenized bonds and digital asset management | - Regulatory uncertainty for digital assets | | **Digital Infrastructure** | - AI-driven infrastructure for tokenization and IP conversion | - Cybersecurity risks in blockchain ecosystems | --- ### 📊 **Why These Sectors?** 1. **Healthcare Technology**: UBS highlighted Medtronic’s Q2 2026 outperformance, driven by AI-integrated cardiovascular and neuroscience solutions . The bank raised its price target for Medtronic stock, signaling confidence in AI’s role in medical innovation. 2. **Financial Services**: UBS’s partnership with Ant International to develop blockchain-based cross-border payments underscores the sector’s growth potential . This aligns with UBS’s broader focus on digital asset infrastructure . 3. **Digital Infrastructure**: UBS’s move to tokenize intellectual property (IP) and bonds reflects a strategic bet on AI’s ability to revolutionize asset management and risk assessment. --- ### 📊 **Risks to Watch** - **Private Credit Exposure**: AI firms reliant on private credit face a 30%–40% risk of impairment if the sector faces a downturn . - **Regulatory Uncertainty**: Blockchain and digital asset projects remain subject to evolving regulations, particularly in Switzerland . - **Market Volatility**: Tokenized assets and cross-border payment systems are inherently volatile, with transaction volumes fluctuating based on macroeconomic conditions . --- ### 📊 **Investor Takeaway** 🎯 For a **moderate-risk, long-term strategy**, prioritize **healthcare AI** (e.g., Medtronic’s PFA technology) and **financial AI** (e.g., UBS’s blockchain partnerships). Diversify with **digital infrastructure** plays but remain cautious about private credit risks. Stay aligned with UBS’s strategic bets while monitoring regulatory developments closely. Query |code|market_code|stock code|stock name|Last Price|Last Change|Theme|Inclusion Reason| |---|---|---|---|---|---|---|---| |CRCL|169|CRCL.N|Circle|68.4799|2.315703||| |COIN|185|COIN.O|Coinbase Global|235.32|-1.1924759999999999||| |FLD|186|FLD.O|Fold Holdings|2.98|-1.6501649999999999||| |BTDR|186|BTDR.O|Bitdeer|9.97|-1.7733990000000002||| |BTCS|186|BTCS.O|BTCS|2.6550000000000002|-2.0295199999999998||| |BTBT|186|BTBT.O|Bit Digital|1.995|-2.682927||| |MARA|186|MARA.O|MARA Holdings|9.92|-3.125||| |SLAI|169|SLAI.N|Solai|1.3151|-3.3014710000000003||| |HUT|185|HUT.O|Hut 8|32.59|-3.4656399999999996||| |CAN|185|CAN.O|Canaan|0.8908|-3.5199830000000003|||